Tipifarnib and Bortezomib in Treating Patients With Relapsed Multiple Myeloma

Clinical trial NCT00243035 · TERMINATED

Trial details

NCT number: NCT00243035
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Refractory Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma

Start date: 2005-08-01
Primary completion: 2007-02-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.